Competition rules and health care players: principles and consequences
Author:
Fornaciari Diego,Callens Stefaan
Abstract
PurposeCompetition rules maximise consumer welfare by promoting efficient use of scarce resource and thus high output, low prices, high quality, varied services, innovation, production and distribution. European courts consider doctors and hospital staff as undertakings (any entity that performs economic activities), so that if they enter into agreements then they have to comply with competition rules. This paper's objective is to determine whether competition law, which applies to undertakings, can in fact be applied to different healthcare‐sector players and whether specific rules are needed regarding competition between healthcare undertakings.Design/methodology/approachData were selected from relevant European and national case law, European institution legal documents (such as regulations, guidelines and communications) and healthcare competition law literature, and then examined.FindingsThe paper finds that competition rules are applicable to healthcare players considering the consequences if competition rules are applied to the healthcare market. For market processes to result in the appropriate cost, quality and output, competition law must be proactive. In other words, quality must be fully factored into the competitive mix, allowing consumers to weigh healthcare price and non‐price characteristics.Research limitations/implicationsCountries have different healthcare system and competition rules (although similar), competition rule impact is different for each country. Some healthcare systems are more regulated and there will be less opportunity for healthcare players to compete.Practical implicationsEfficiently applying competition law to healthcare players means that several challenges need facing, such as healthcare quality complexity and court scepticism.Originality/valueThis article points out the challenges when competition law is applied to the healthcare sector and how these challenges are faced in certain countries such as The Netherlands.
Subject
Health Policy,General Business, Management and Accounting
Reference18 articles.
1. ABA Publishing (2004), Antitrust Healthcare Handbook, 3rd ed., ABA Section of Antitrust Law, ABA Publishing, Chicago, IL. 2. Callens, S. and Fornaciari, D. (2008), “Mededinging en gezondheidszorg”, in Callens, S. and Peers, J. (Eds), Organisatie van de gezondheidszorg, Intersentia, Antwerp and Oxford, pp. 637‐60. 3. Cannon, M. and Tanner, M. (2005), Healthy Competition, What's Holding back Healthcare and How to Free It, Cato Institute, Washington, DC. 4. Custers, T., Aarah, O.A. and Klazinga, N.S. (2006), “Is there a business case for quality in The Netherlands? a critical analysis of the recent reforms of the healthcare system”, Health Policy, Vol. 82 No. 2, pp. 226‐39. 5. Darba, J. and Rovira, J. (1998), “Parallel imports of pharmaceuticals in the European Union”, Pharmacoeconomics, Vol. 14, pp. 129‐36.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|